Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR9 | P51686 | 1/20 | 0.35 |
| ▸ | DPP4 | P27487 | 1/20 | 0.34 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | COMT | P21964 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4793568 | 0.82 | CCR9 (0.36) | CCR9DPP4LOXL2KMT2ACA1 | |
| SCHEMBL4793133 | 0.77 | KMT2A (0.39) | CCR9DPP4LOXL2KMT2ACA1 | |
| SCHEMBL4777327 | 0.75 | KCNA5 (0.41) | CA1CA2CA9KDM4E | |
| SCHEMBL2491544 | 0.71 | DPP4 (0.47) | DPP4LOXL2KDM4EMAPT | |
| SCHEMBL3287856 | 0.70 | DPP4 (0.43) | DPP4LOXL2KDM4E | |
| SCHEMBL20818541 | 0.69 | DPP4 (0.40) | DPP4LOXL2 | |
| SCHEMBL2585449 | 0.67 | PSIP1 (0.46) | LOXL2KMT2ACA1CA2CA9 | |
| SCHEMBL16547434 | 0.67 | DPP4 (0.43) | DPP4LOXL2KDM4EMAPT | |
| SCHEMBL17778287 | 0.67 | DPP4 (0.40) | DPP4LOXL2KDM4EMAPT | |
| SCHEMBL12732660 | 0.67 | NPC1 (0.39) | KMT2AKDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1924561-A2 | 6-ARYLALKYLAMINO- 2,3,4,5-TETRAHYDRO-1H-BENZO[D]AZEPINES AS 5-HT2C RECEPTOR AGONISTS | Eli Lilly & Company (US) | 2008-05-28 | — | — | EP | disclosed |
| WO-2007028083-A2 | 6-ARYLALKYLAMINO- 2,3,4,5-TETRAHYDRO-1H-BENZO[D]AZEPINES AS 5-HT2C RECEPTOR AGONISTS | ELI LILLY AND COMPANY (US) | 2007-03-08 | — | — | WO | disclosed |